News
Dr. Reddy’s signs MoU to receive 100 million doses of Russian Covid Vaccine Sputnik V vaccine
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ABLE member, Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine
SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for Covid-19, on September 15 submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial of the Covid Vaccine.
A Kerala BioPharma company gets DCGI nod for Phase-2 clinical trial for novel drug to treat COVID-19
The 9-year, startup, PNB Vesper Lifesciences claims its PNB-001, a molecule that can reduce pro-inflammatory cytokines (IL-6), is the world’s first novel chemical entity to treat COVID-19. The molecule development has been funded by BIRAC under government of India.
Affigenix get regulatory nod to make 3 COVID-19 home-made diagnostic kits
ABLE member, Affigenix Biosolutions, a startup based in Bangalore, can now start manufacture and sale of three diagnostic kits, Affimag, Affispin and Affigenix COVID-19 test (ACT) RT-QPCR kits for diagnosis of COVID-19.
voice for BT and BEST 2026
